A REGISTRY OF CHRONIC INFLAMMATORY BOWEL DISEASE IN SOUTH EASTERN NORWAY (THE IBSEN STUDY GROUP) – 20 years follow-up of an inception cohort.
- Prosjektnummer
- 2010009
- Ansvarlig person
- Bjørn Moum
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer, Inflammatory and Immune System
- Forskningsaktivitet
- 6. Treatment Evaluation, 7. Disease Management
Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study.
Inflamm Bowel Dis 2016 Jan;22(1):141-5.
PMID: 26355464
Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
Scand J Gastroenterol 2016;51(5):548-55. Epub 2015 des 4
PMID: 26634305
Patients' perceptions of quality of care and follow-up in inflammatory bowel disease.
Scand J Gastroenterol 2016;51(4):434-41. Epub 2015 des 4
PMID: 26635189
Patient-performed extraction of faecal calprotectin.
Clin Chem Lab Med 2016 Aug 01;54(8):1357-63.
PMID: 26812797
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Gut 2017 Apr;66(4):611-619. Epub 2016 feb 17
PMID: 26887816
Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.
Mucosal Immunol 2016 Nov;9(6):1455-1465. Epub 2016 mar 16
PMID: 26982597
Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.
Inflamm Bowel Dis 2016 Jul;22(7):1679-87.
PMID: 27206016
Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.
World J Gastrointest Pharmacol Ther 2016 May 06;7(2):235-41.
PMID: 27158539
Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease.
Can J Gastroenterol Hepatol 2016;2016():5624261. Epub 2016 jun 19
PMID: 27446848
Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis.
Gastroenterol Res Pract 2016;2016():5023973. Epub 2016 aug 18
PMID: 27630711
Malignancies in patients with inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study.
J Crohns Colitis 2016 Oct 31. Epub 2016 okt 31
PMID: 27799270
The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life.
Gastroenterol Res Pract 2016;2016():6453657. Epub 2016 nov 27
PMID: 28003821
Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).
Scand J Gastroenterol 2015;50(12):1456-62. Epub 2015 jul 3
PMID: 26139389
Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
Scand J Clin Lab Invest 2015 Sep;75(5):355-61. Epub 2015 apr 9
PMID: 25856663
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.
Hepatology 2015 Jul;62(1):188-97. Epub 2015 apr 28
PMID: 25833813
Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease.
Scand J Gastroenterol 2015;50(9):1183-4. Epub 2015 mar 15
PMID: 25772406
[Iron deficiency and iron deficiency anemia are global health problems].
Lakartidningen 2015;112(). Epub 2015 mar 10
PMID: 25756711
Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis.
Inflamm Bowel Dis 2015 Feb;21(2):337-44.
PMID: 25569735
Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Scand J Gastroenterol 2015 Mar;50(3):300-5. Epub 2014 des 23
PMID: 25535653
High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies.
Infect Dis (Lond) 2015 Mar;47(3):137-43. Epub 2014 des 18
PMID: 25522183
Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
J Crohns Colitis 2015 Feb;9(2):164-9.
PMID: 25518057
Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study).
Inflamm Bowel Dis 2014 Jan;20(1):60-8.
PMID: 24280875
Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies.
Ann Gastroenterol 2014;27(2):95-104.
PMID: 24733679
Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study.
Gut 2014 May;63(5):771-5. Epub 2013 jun 6
PMID: 23744613
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
Gut 2013 Mar;62(3):368-75. Epub 2012 jun 20
PMID: 22717453
Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission.
Gastroenterol Res Pract 2013;2013():620707. Epub 2013 feb 6
PMID: 23476638
Fatigue interference with daily living among patients with inflammatory bowel disease.
Qual Life Res 2013 Aug 23. Epub 2013 aug 23
PMID: 23975381
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
Inflamm Bowel Dis 2013 Sep;19(10):2111-7.
PMID: 23883959
Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Scand J Gastroenterol 2012 Dec;47(12):1436-47. Epub 2012 sep 25
PMID: 23003678
Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study.
J Crohns Colitis 2012 May;6(4):441-53. Epub 2011 nov 9
PMID: 22398064
Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study.
Inflamm Bowel Dis 2012 Aug;18(8):1540-9. Epub 2011 sep 20
PMID: 21936030
A Risk Matrix Model for the Prediction of Intestinal Tuberculosis and Differentiation from Crohn’s Disease.
Austin J Gastroenterol. 2015; 2(5): 1052. ISSN : 2381-9219 | www.austinpublishinggroup.com
Clinical Course,Treatment ,Social and Economic Impact of Ulcerative Colitis: An Overview.
Austin J Gastroenterol. 2014;1(4): 9. ISSN : 2381-9219 | www.austinpublishinggroup.com
Clinical course and prognosis in ulcerative colitis: results from population based and observational studies
Annals of Gastroenterology 2013 (Okt),
Mortality and causes of death in Crohn´s disease: Results from a Norwegian population-based twenty-year follow-up study
European Crohn´s and Colitis Organisation ( ECCO), Wien februar 2013. J Crohns Colitis 2013;Page S263 (Poster 629)
Mortality and causes of death in ulcerative colitis (UC)
European Crohn´s and Colitis Organisation (ECCO), Wien februar 2013. J Crohns Colitis 2013;7S1:9 A20
Dødsårsaker hos pasienter med Crohns sykdom: Resultater fra en norsk populasjonsbasert 20 års oppfølgingsstudie
Norsk Gastroenterologisk Forenings Årsmøte, februar 2013. NGF Nytt Abstract Bok 2013 (Oral presentasjon).
”Ikke økt dødelighet ved Crohns sykdom”. Omtale av artikkel i Tidsskrift for den norske legeforening
Tidsskr Nor legeforen 16, 2013:133.
”Viktig for Crohns-pasienter”.
SI-magasinet 4/2013, s. 23. (Internt magasin for Sykehuset Innlandet: Artikklen blir også publisert på forskning.no)
Intestinal tuberculosis: diagnosis and differentiation from Crohn's disease in a resource--limited setting
- Disputert:
- desember 2015
- Hovedveileder:
- Bjørn Moum
Living with inflammatory bowel disease – the impact on health-related quality of life and work disability. Ten-year results fro
- Disputert:
- oktober 2012
- Hovedveileder:
- Bjørn Moum
- Gert Huppertz-Hauss Prosjektdeltaker
- Tomm Bernklev Prosjektdeltaker
- Bjørn Moum Prosjektleder
- Ole Ingebreth Høie Prosjektdeltaker
- Morten Vatn Prosjektdeltaker
- Aida Kapic Doktorgradsstipendiat (annen finansiering)
- Anne Negard Hovedveileder
- Randi Opheim Prosjektdeltaker
- Jørgen Jahnsen Prosjektdeltaker
- Magne Henriksen Medveileder
- Inger Camilla Solberg Prosjektdeltaker
- Iril Lovise Kempski-Monstad Doktorgradsstipendiat (annen finansiering)
- Øistein Hovde Doktorgradsstipendiat (finansiert av denne bevilgning)
- Marte Høivik Prosjektdeltaker
- Milada C Småstuen Prosjektdeltaker
- Johannes Espolin Roksund Hov Prosjektdeltaker
- Morten H Vatn Prosjektdeltaker
- Idar Lygren Prosjektdeltaker
- Pasquale Catherine Klepp Doktorgradsstipendiat
- May-Bente Bengtson Prosjektdeltaker
- Øyvind Palm Prosjektdeltaker
- Tom Hemming Karlsen Prosjektdeltaker
- Njaal Stray Prosjektdeltaker
- Arne Sigmund Borthne Prosjektdeltaker
- Stephan Brackmann Hovedveileder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport